Efficacy of proactive therapy by topical corticosteroids for atopic dermatitis

Efficacy of proactive therapy by topical corticosteroids for atopic dermatitis - proactive therapy for atopic dermatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005059

Enrollment

Registered

2011-02-09

Start date

2011-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

Four weeks topical betamethasone butyrate propionate following daily emolients and betamethasone butyrate propionate at twice a week Four weeks topical betamethasone butyrate propionate following dail

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: consented adult patients with intermediate severity of atopic dermatitis with

Exclusion criteria

Exclusion criteria: hypersensitivity of betamethasone butyrate propionate and/or emollients disability of judgement

Design outcomes

Primary

Measure	Time frame
SCORAD IGA DLQI itchy VAS side effects of topical steroids frequency of medication	—

Countries

Japan

Contacts

Public ContactYukiko Kiniwa

Shinshu university school of medicine Department of dermatology

ykiniwa@shinshu-u.ac.jp0263-37-2647

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026